1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Investigator Initiated Studies (IIS) is sponsored by Pfizer. Pfizer supports Investigator Initiated Studies (IIS) projects that advance medical and scientific knowledge about Pfizer's therapies. This includes pre-clinical and clinical studies involving a Pfizer asset (e.g., commercial drug, investigational drug, pure compound).
Pfizer also supports general research projects focused on the development or refinement of specific and defined medical knowledge unrelated to a Pfizer asset.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Third-party investigators or clinicians seeking funding for investigator-initiated studies or research collaborations. Confirm the full requirements in the official notice before applying.
Investigator Initiated Studies (IIS) is funded by Pfizer. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program